P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?

Curr Vasc Pharmacol. 2023 Nov 23. doi: 10.2174/0115701611269735231106110250. Online ahead of print.NO ABSTRACTPMID:38018206 | DOI:10.2174/0115701611269735231106110250

Source: Current Vascular Pharmacology - November 29, 2023 Category: Drugs & Pharmacology Authors: Felice Gragnano Antonio Capolongo Paolo Calabr ò Source Type: research